Back

Non-vitamin K oral anticoagulants for cardioversion: recent trials.

28 August 2017 (17:37 - 18:00)
Organised by:
Congress Presentation Part of: Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Michael Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)

3 More presentations in this session

Presentation thumbnail
Early cardioversion: is there strong evidence to support the concept?
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
Practical considerations for cardioversion of atrial fibrillation.
Doctor R. Cappato (Sesto San Giovanni, IT)
Slides Video
Presentation thumbnail
Dealing with left atrial appendage clot
Associate Professor F. Marin (Murcia, ES)
Slides Video

Access the full session

Session thumbnail
Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

The Event

Event poster

ESC Congress 2017

28 August 2017 17:37 CET
You may be interested in
thumbnail
Congress Presentation
Comparing novel oral anticoagulants to vitamin k antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation: an updated systematic review and meta-analysis
7 April 2022
thumbnail
Congress Presentation
Predictors of maintenance of sinus rhythm one year after successful cardioversion of persistent atrial fibrillation and atrial flutter
12 April 2026
thumbnail
Congress Session
Stroke and bleeding risk in atrial fibrillation: walking the tight rope
25 August 2023
thumbnail
Congress Session
Arrhythmias during pregnancy: help and not harm
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources